Cellectar Biosciences Files 8-K: Other Event

Ticker: CLRB · Form: 8-K · Filed: Jun 26, 2025 · CIK: 1279704

Cellectar Biosciences, Inc. 8-K Filing Summary
FieldDetail
CompanyCellectar Biosciences, Inc. (CLRB)
Form Type8-K
Filed DateJun 26, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 8-K, disclosure, regulatory-filing

TL;DR

Cellectar filed an 8-K for an 'Other Event' on 6/26/25. Details TBD.

AI Summary

Cellectar Biosciences, Inc. filed an 8-K on June 26, 2025, reporting an "Other Event." The filing does not contain specific details about the event, dollar amounts, or definitive dates beyond the filing date itself. It primarily serves as a notification of an event requiring disclosure under SEC regulations.

Why It Matters

This filing indicates that Cellectar Biosciences has experienced a material event that requires public disclosure, though the specifics are not yet detailed. Investors should monitor for subsequent filings that clarify the nature of this event.

Risk Assessment

Risk Level: medium — The filing indicates a material event has occurred, but the lack of detail creates uncertainty and potential risk for investors until more information is provided.

Key Players & Entities

  • Cellectar Biosciences, Inc. (company) — Registrant
  • June 26, 2025 (date) — Filing date and earliest event reported
  • Delaware (jurisdiction) — State of incorporation
  • Florham Park, NJ (location) — Principal executive offices

FAQ

What specific event is Cellectar Biosciences reporting in this 8-K filing?

The filing is categorized under 'Other Events' and does not provide specific details about the event itself within the provided text.

When was this 8-K filing submitted to the SEC?

The filing was submitted on June 26, 2025.

What is the exact name of the company filing this report?

The exact name of the registrant is Cellectar Biosciences, Inc.

In which state is Cellectar Biosciences, Inc. incorporated?

Cellectar Biosciences, Inc. is incorporated in Delaware.

What is the principal executive office address for Cellectar Biosciences, Inc.?

The principal executive offices are located at 100 Campus Drive, Florham Park, NJ, 07932.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 26, 2025 regarding Cellectar Biosciences, Inc. (CLRB).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.